UNSPSC 51172119: Butaverine

This classification denotes an antispasmotic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1I5O5WIU8X. European Medicines Agency schedules Butaverine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06009MIG. Butaverine generally arises in the molecular formula C18H27NO2.

The term BUTAVERINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, list 5.) BUTAVERINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule butaverine under HS 29333999 and SITC 51574. As of Q4 2014, BUTAVERINE remains the US FDA Preferred Term for this commodity. Butaverine bears US NLM identifiers UMLS ID C0771071 and NCI Concept Code C73169. SMILES: O(C(=O)CC(N1CCCCC1)C1CCCCC1)CCCC.

UNSPSC 51172119 Butaverine is a Commodity code that state and local governments are not actively soliciting. The three most recent state and local opportunities tagged to this code show no material purchasing activity for butaverine itself. The Collin County Community Supervision and Corrections Department RFP 2026-327, due July 23, 2026, solicits offender specimen collection and drug testing services—immunoassay screening with LC/MS/MS or GC/MS confirmation, oral fluid and hair testing, and Interactive Voice Response notifications—for approximately 25,031 tests annually at an estimated contract value of $600,000 over two years with optional renewals through five years total. The Texas Health and Human Services Commission RFI HHS0017013, posted April 3, 2026, gathers market intelligence on direct-to-manufacturer prescription programs and pharmacy benefit management strategies rather than procuring specific pharmaceutical products. The Minnesota Multistate Cooperative Purchasing Alliance RFP S1070000015802, due March 26, 2026, establishes contracts for generic multi-source pharmaceuticals and OTC products across state and local facilities in Minnesota and Oregon, with awarded vendors required to supply through three authorized wholesalers and maintain cGMP and DSCSA compliance, with pricing weighted at 75 percent of the evaluation and a two-year contract term with optional extensions. None of these solicitations targets butaverine or other specific active pharmaceutical ingredients by name.

The issuing bodies represent a state department (Texas HHS), a county corrections agency (Collin County), and a multistate cooperative purchasing vehicle (MMCAP administered by Minnesota). Geographic activity spans Texas, Minnesota, and Oregon. The code shows no concentrated or repeated activity and no solicitations specifically demanding butaverine as a procured input. Business development professionals should treat this code as inactive for state and local procurement purposes; the tagging of these three opportunities to UNSPSC 51172119 does not reflect purchasing intent for butaverine itself.